This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AKU Akumin (AKU) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Akumin Stock (NASDAQ:AKU) 30 days 90 days 365 days Advanced Chart Get Akumin alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.13▼$0.3652-Week Range N/AVolume8.54 million shsAverage Volume1.38 million shsMarket Capitalization$26.32 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida. Read More Receive AKU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter. Email Address AKU Stock News HeadlinesBroward radiology firm names CEOApril 1, 2025 | bizjournals.comAkumin and United Imaging Announce Multi-year, Multi-modality Strategic AllianceNovember 18, 2024 | finance.yahoo.comThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending. | Crypto Swap Profits (Ad)Allied Gold: Top 10 Undervalued Growth Stocks on TSX (AAUC)August 23, 2024 | theglobeandmail.comKalloghlian Myers LLP: Leave and Certification Granted in Akumin Inc. Securities Class ActionJuly 30, 2024 | tmcnet.comAdcore: Top 10 Undervalued Growth Stocks on TSX (ADCO)July 26, 2024 | theglobeandmail.comAlmonty Indus: Top 10 Undervalued Growth Stocks on TSX (AII)July 26, 2024 | theglobeandmail.comAKUMIN ANNOUNCES PARTNERSHIP WITH NORTHERN NEVADA SIERRA MEDICAL CENTER FOR RADIATION ONCOLOGY SERVICESFebruary 21, 2024 | finance.yahoo.comSee More Headlines AKU Stock Analysis - Frequently Asked Questions How were Akumin's earnings last quarter? Akumin Inc. (NASDAQ:AKU) released its earnings results on Monday, December, 13th. The company reported ($0.02) earnings per share for the quarter, beating analysts' consensus estimates of ($0.43) by $0.41. The firm had revenue of $108.18 million for the quarter, compared to analysts' expectations of $109.25 million. Akumin had a negative net margin of 30.56% and a negative trailing twelve-month return on equity of 167.86%. What other stocks do shareholders of Akumin own? Based on aggregate information from My MarketBeat watchlists, some other companies that Akumin investors own include Labor Smart (LTNC), NVIDIA (NVDA), Heatwurx (PCSA), Acrivon Therapeutics (ACRV), Canopy Growth (CGC), AST SpaceMobile (ASTS). Company Calendar Last Earnings12/13/2021Today7/18/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:AKU CIK1776197 Webwww.akumin.com Phone(844) 730-0050FaxN/AEmployees3,631Year FoundedN/AProfitability EPS (Trailing Twelve Months)($2.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$156.76 million Net Margins-30.56% Pretax Margin-28.78% Return on Equity-167.86% Return on Assets-7.81% Debt Debt-to-Equity Ratio17.02 Current Ratio0.99 Quick Ratio0.99 Sales & Book Value Annual Sales$749.63 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.24 per share Price / BookN/AMiscellaneous Outstanding Shares91,170,000Free Float72,473,000Market Cap$26.32 million OptionableNot Optionable Beta-0.72 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:AKU) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akumin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akumin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.